Does Your Ad Have Too Many Pictures?

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

You can't have your cake and eat it too.

Introduction I always feel guilty when I go see the dentist. We all know the rules—avoid sweets, brush after every meal, floss several times a day. Talking about tool and shop safety gets the same treatment in articles and books– always read the owner’s manual, inspect your tool for hazards daily, make sure your tools are properly grounded (sound familiar?) The challenge I present to you is tha...

متن کامل

Paint Your Own Pictures

In these days when everyone seems interested in "art therapy" this book is very timely and it is of special interest to our readers that the author has had considerable experience with psychiatric patients. He has dedicated it to Dr.

متن کامل

How many "me-too" drugs is too many?

ON AUGUST 3, 2009, THE US FOOD AND DRUG ADministration (FDA) approved pitavastatin (Livalo), making it the eighth statin approved for use in the United States and seventh currently available for sale. This approval comes almost a quarter century after that for the first member of the class, lovastatin, 8 years after generic lovastatin was approved and 4 years after 2 additional statins, pravast...

متن کامل

Therapeutic cytapheresis: too many platelets, too many white blood cells.

Myeloproliferative disorders may present with thrombocytosis and/or leukocytosis with symptoms ranging from minor to life-threatening. Therapeutic cytapheresis (TC), the removal of excess and/or abnormal cells such as platelets and white blood cells, can be used to rapidly reduce cells in the symptomatic patient. The patient's clinical status determines the need for TC as symptoms may not corre...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Advertising Research

سال: 2000

ISSN: 0021-8499

DOI: 10.2501/jar-40-1-2-11-27